STAT April 5, 2024
Johnson & Johnson on Friday announced it would acquire heart device firm Shockwave Medical for $13.1 billion. It’s J&J’s second billion-dollar deal in the cardiovascular space in two years, following its 2022 purchase of Abiomed for $16.6 billion.
The company also said in November that it would buy private heart device company Laminar for $400 million.
Shockwave Medical’s device works to break down calcified plaque in the coronary and peripheral arteries...